- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in dr reddys
Q1 Results: Dr Reddy's Labs Profit Soars By 18.2% To Rs 1,405 Cr
Dr Reddy's Laboratories on Wednesday announced its consolidated financial results for the quarter ended June 30, 2023. The company reported revenue growth of 29.1 per cent YoY and 7.0 per cent QoQ to Rs. 6,758 crores and above market expectations of Rs. 6,343 crores
Read More
Dr Reddy’s Posts 18% Profit Due To High Sales In North America, Russia
Quarterly revenue was boosted by Lenalidomide sales and revenue growth of 75 per cent in Russia, compared to last year, the company added
Read More
Dr Reddy’s Completes Phase I Study Of Biosimilar Of Tocilizumab
Dr Reddy’s Laboratories, a global pharmaceutical company, said that its tocilizumab biosimilar candidate, DRL_TC, successfully met its primary and secondary endpoints in Phase I clinical study, the company said in an exchange filing on Monday
Read More
Dr Reddy's Labs Reports 11-fold Increase In Q4 Profit
The Hyderabad-based company's consolidated profit rose to Rs 959 crore in the three months ended 31 March, compared with Rs 875 crore a year earlier
Read More
Dr Reddy's Q3 Net Profit Rises Multi-fold To Rs 707 Cr
Revenues stood at Rs 5,319.7 crore during the third quarter as compared with Rs 4,929.6 crore in the same period of 2020-21, Dr Reddy's Laboratories said.
Read More
DRDO Develops Survival Kit For Troops Deployed At Minus 50 Degrees Celcius
Import substitution technology for extreme cold weather gear handed over to 5 Indian companies
Read More
Mansukh Mandaviya Holds Meeting With Dr Reddy's Lab Chairman On Sputnik V Production, Supply
The Hyderabad-based drug major has already stated that the locally manufactured Sputnik V will be available from September-October period.
Read More
Sputnik V Soft Launched In Over 50 Cities In India: Dr Reddys
The Indian drug regulator has granted permission for restricted emergency use of SputnikV, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.
Read More
Dr Reddy's Bullish On OTC Products Sale Through Amazon, Others In US
Dr Reddys had three late projects at different levels of development, ranging from products that have completed Phase 2 clinical trials to a product that is undergoing pivotal studies for registration.
Read More
Dr Reddy's Expects Biz Growth To Be Volatile In Current Fiscal
Higher productivity is also enabled by scaling up of robotic process automation (RPAs) as well as digitalised processes with automated incident tracking and near zero manual errors
Read More
Dr Reddy's Lines Up Rs 1,000 Cr Capex For Current Fiscal
The drug maker's growth would be primarily driven by organic moves, focusing around pipeline monetisation, productivity enhancement, diversifications and capability ramp-up in marketing and digitalisation
Read More
Dr Reddy's In Talks With RDIF On Sputnik V For Other Countries
RDIF has tied up with six Indian drug makers to manufacture Sputnik V and their supplies are expected to roll out by August or September
Read More
Dr Reddy's Q4 Profit Dips 29 Pc To Rs 557 Cr
Net sales however rose to Rs 4,608 crore in the quarter under review as compared with Rs 4,336.1 crore in the fourth quarter of 2019-20
Read More
Dr Reddy's Inks Licensing Pact With Eli Lilly For COVID-19 Treatment Drug
The Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialisation of the drug in India.
Read More
Dr Reddy's Launches Generic Drug In US Market
The Albenza brand and generics had sales of around USD 27 million in the US for the most recent twelve months ending in November 2020.
Read More